ESR1 and metabolic dysfunction-associated steatotic liver disease: One study highlighted that estrogen-related receptor α, which acts downstream of estrogen/estrogen receptor α signaling, is a mediator modulating hepatic triglyceride-rich very low-density lipoprotein (VLDL-TG) assembly and secretion, which might contribute to the sex disparity in NAFLD development [34].